Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale | SELL | $5.91M 122.6K sh | Mar 26, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $24K 1,097 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $804 37 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $18K 833 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 32 | Li Jeffrey KSVP and Secretary |  KEYSKeysight Technologies, Inc.Open-market sale | SELL | $594K 2,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 31 | Flores JessicaExecutive VP & CAO |  SBRASabra Health Care REIT, Inc.Open-market sale | SELL | $302K 15.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 31 | Halter Timothy PDirector |  DXPEDXP ENTERPRISES INCOpen-market sale | SELL | $698K 5,000 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 31 | Zitkus LesterSVP, Land |  GPORGULFPORT ENERGY CORPOpen-market sale | SELL | $401K 1,873 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 30 | Balcom AlexandraChief Financial Officer |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $735K 7,671 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 29 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $1.37M 13.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 29 | Tonnel David AChief Accounting Officer |  SMRNUSCALE POWER CorpOpen-market sale | SELL | $27K 2,290 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Morais Silvio JoseDirector |  STNEStoneCo Ltd.Open-market sale | SELL | $97K 6,800 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Dhanasekaran SatishDirector, President and CEO | KEYSKeysight Technologies, Inc. Open-market sale | SELL | $500K 1,667 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 28 | Murphy Matthew JDirector, Chairman of the Board and CEO |  MRVLMarvell Technology, Inc.Open-market sale · 10b5-1 plan | SELL | $2.96M 30.0K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 25 | Owens Bradley D.General Counsel |  ZANDZGZILLOW GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $384K 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 1,160 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $247K 2,599 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 22 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $272K 19.1K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 22 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $269K 19.1K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 18 | Samuelson Errol GChief Industry Dev. Officer | ZANDZGZILLOW GROUP, INC. Open-market sale · 10b5-1 plan | SELL | $209K 4,734 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $261K 19.1K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $32K 5,492 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $29K 5,319 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 14 | Bowe Patrick E.Director |  ANDEAndersons, Inc.Open-market sale · 10b5-1 plan | SELL | $1.03M 14.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $39K 7,098 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Werner Edward CooperChief Financial Officer | FFIVF5, INC. Open-market sale · 10b5-1 plan | SELL | $300K 1,000 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $9,585 1,500 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary | ASANAsana, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 5,015 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Bowe Patrick E.Director | ANDEAndersons, Inc. Open-market sale · 10b5-1 plan | SELL | $58K 800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Raben DavidChief Medical Officer |  BCAXBicara Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $104K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Low RussellDirector, PRESIDENT AND CEO |  ACLSAXCELIS TECHNOLOGIES INCOpen-market sale · 10b5-1 plan | SELL | $112K 1,244 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 4 | Misra AmitabhChief Technology Officer |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $243K 41.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 44 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.03M 12.6K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $431K 5,140 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $131K 1,541 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $212K 2,504 sh | Mar 25, 2026 traded Mar 23, 2026 |